GALETZKA, D.; BÖCK, J.; WAGNER, L.; DITTRICH, M.; SINIZYN , O.; LUDWIG, M.; ROSSMANN, H.; SPIX, C.; RADSAK, M.; SCHOLZ-KREISEL, P.; MIRSCH, J.; LINKE, M.; BRENNER, W.; MARRON, M.; POPLAWSKI, A.; HAAF, T.; SCHMIDBERGER, H.; PRAWITT, D. Hypermethylation of RAD9A intron 2 in childhood cancer patients, leukemia and tumor cell lines suggest a role for oncogenic transformation. EXCLI Journal, [S. l.], v. 21, p. 117–143, 2022. DOI: 10.17179/excli2021-4482. Disponível em: https://www.excli.de/index.php/excli/article/view/4482. Acesso em: 7 oct. 2022.